GeraldASoffMD

Clotting Disorder, Hemophilia & Bleeding Disorder, Myeloproliferative Disorder Hematology-Oncology

Chief, Classical Hematology Service, University of Miami Health System/Sylvester Comprehensive Cancer Center

Dr. Soff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1985 - 1991
Virginia Commonwealth University Health SystemResidency, Internal Medicine, 1981 - 1984
Johns Hopkins University School of MedicineClass of 1981

PubMed

Abstracts/Posters

Extended Mutational Profiling By MSK-IMPACTTM Identifies Mutations Predicting Thromboembolic Risk in Patients with Solid Tumor MalignancyClinically Relevant Abstract
Gerald A. Soff, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Burden of thrombocytopenia in adult cancer patients receiving chemotherapy.
2019 ASCO Annual Meeting - 6/1/2019

Excellence in Care of Sickle Cell Disease Leads to National RecognitionOctober 27th, 2021
Surprise Find in COVID-19 Brain CapillariesFebruary 17th, 2021
Dr. Gerald Soff Recalls His Battle with Myeloma; Lauds ICRF & Sloan Kettering for Outstanding WorkAugust 21st, 2019
Join now to see all

Histone Deacetylase Inhibitors For Cancer TreatmentNational Cancer Institute2005
Generation Of And Angiostatin Level In Prostate CancerNational Cancer Institute2001–2002
Angiostatic Therapy For Breast Cancer--A TranslationalNational Cancer Institute2000–2002
Angiostatin Level In Prostate CancerNational Cancer Institute2001
Plasminogen/Angiostatin Converting EnzymeNational Cancer Institute1997–2000